Physician profile
Scott D Brown
NPI 1285695171
$1,788.20
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $609 · 2021: $17.78 · 2022: $87.06 · 2023: $67.86 · 2024: $75.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $263.81 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $235.96 | 2019-2024 | Breztri |
| Novo Nordisk INC | $194.77 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $161.28 | 2019-2023 | Mounjaro, Trulicity |
| Amgen INC. | $159.65 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.56 | 2019-2020 | |
| Astellas Pharma US INC | $112.98 | 2019-2023 | Myrbetriq |
| Merck Sharp & Dohme LLC | $90.33 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $57.82 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $41.73 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $38.53 | 2020-2022 | |
| Abbvie INC. | $36.79 | 2022 | |
| Allergan, INC. | $36.22 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $36.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.88 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $30.68 | 2019-2021 | |
| Esperion Therapeutics, INC. | $19.75 | 2020 | |
| Alkermes, INC. | $16.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.74 | 2019 | |
| Exact Sciences Corporation | $14.46 | 2024 | Cologuard Collection Kit |
| Tris Pharma INC | $14.41 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.09 | 2019 | |
| Cranial Technologies, INC | $13.38 | 2019 | |
| Sanofi Pasteur INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.